Test - Bimatoprost 0.01% Ophthalmic Solution
CBCC/2021/025
Phase 3 small_molecule active
Quick answer
Test - Bimatoprost 0.01% Ophthalmic Solution for Glaucoma, Open-Angle is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Glaucoma, Open-Angle
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active